Company Overview and News

1
KeyCorp's (KEY) CEO Beth Mooney on Q2 2018 Results - Earnings Call Transcript

19m seekingalpha
Good morning and welcome to KeyCorp’s Second Quarter 2018 Earnings Conference Call. As a reminder, this conference is being recorded.
DB MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG CYHT MS MS.PRA KEY

1
KeyCorp 2018 Q2 - Results - Earnings Call Slides

2h seekingalpha
The following slide deck was published by KeyCorp in conjunction with their 2018 Q2 earnings call.
KEY

1
KeyCorp (KEY) Q2 Earnings Beat, Fee Income & Expenses Rise

6h zacks
KeyCorp’s (KEY - Free Report) second-quarter 2018 earnings of 44 cents per share surpassed the Zacks Consensus Estimate of 42 cents. Also, this compared favorably with earnings of 36 cents recorded in the prior-year quarter. Shares of KeyCorp have gained almost 2% in pre-market trading. Notably, the stock’s price performance after the full day’s trading will give a better indication about investors’ sentiments.
STI.WS.B STI.WS.A STI CMA STI-A STI.PRE KEY

4
KeyCorp (KEY) Beats Q2 Earnings, Revenues Up Marginally

8h zacks
Have you been eager to see how KeyCorp (KEY - Free Report) performed in Q2 in comparison with the market expectations? Let’s quickly scan through the key facts from this Cleveland-based bank-oriented financial services company’s earnings release this morning: An Earnings Beat KeyCorp came out with earnings per share of 44 cents, outpacing the Zacks Consensus Estimate of 42 cents. Rise in revenue and lower expenses supported the results.
NBRV EIGR KEY NCS

1
KEY / KeyCorp 8-K (Current Report)

9h sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
KEY

2
What's in the Offing for Citizens (CFG) in Q2 Earnings?

2018-07-18 zacks
Citizens Financial Group (CFG - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before the market opens. The company is expected to witness year-over-year growth in revenues and earnings.
CFG CFIN STI.WS.B STI.WS.A STI CIWV STI-A STI.PRE KEY

16
What to Expect From People's United (PBCT) in Q2 Earnings?

2018-07-18 zacks
People's United Financial, Inc. (PBCT - Free Report) is scheduled to report second-quarter 2018 results on Jul 19. Both revenues and earnings are anticipated to show year-over-year improvement.
STI.WS.B GEC GE STI.WS.A STI STI-A PBCT GNE STI.PRE KEY

17
Can Interest Income Aid Capital One's (COF) Earnings in Q2?

2018-07-18 zacks
Capital One (COF - Free Report) is slated to release second-quarter 2018 results tomorrow, after market close. The company will likely witness an increase in total net interest income (NII) on a year-over-year basis. Driven by an improving economy, purchase volume growth and credit card loans (part of broader consumer loan portfolio) continued to increase during the second quarter. This, along with higher interest rates, are likely to support Capital One’s credit card NII.
STT STI.WS.B GEC GE STI.WS.A STT.PRC STT.PRE STT.PRD STT.PRG KEY STI STI-A GNE STI.PRE

18
Will Loan Growth, Fee Income Aid SunTrust (STI) Q2 Earnings?

2018-07-18 zacks
SunTrust Banks (STI - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before the opening bell. Its revenues and earnings are projected to grow year over year. In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate. Results benefited from rise in net interest income as well as lower expenses and provisions. However, a decline in non-interest income was the undermining factor.
STT STI.WS.B GEC GE STI.WS.A STT.PRC STT.PRE STT.PRD STT.PRG KEY STI ETFC STI-A GNE STI.PRE

3
Can Higher Rates Aid State Street's (STT) Earnings in Q2?

2018-07-18 zacks
State Street (STT - Free Report) is scheduled to report second-quarter 2018 results on Jul 20, before the market opens. Its earnings and revenues are expected to grow year over year. In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate. Results were aided by an increase in revenues, partly offset by higher expenses. Moreover, State Street boasts an impressive earnings surprise history.
STT HD STI.WS.B STI.WS.A STT.PRC STT.PRE STT.PRD STT.PRG KEY STI ETFC STI-A STI.PRE

7
5 Major Bank Stocks Set to Outpace Earnings Estimates in Q2

2018-07-17 investorplace
The earnings season is knocking at the door and investors are keen to see how major banks have performed in the second quarter amid uncertainty related to the trade war fears.
STI.WS.B STI.WS.A STI JPM CMA STI-A MTB STI.PRE KEY

2
Why is Earnings Beat Less Likely for BNY Mellon (BK) in Q2?

2018-07-17 zacks
The Bank of New York Mellon Corporation (BK - Free Report) is scheduled to report second-quarter 2018 results on Jul 19, before the market opens. Its revenues and earnings are expected to grow year over year. In the last reported quarter, the company’s earnings surpassed the Zacks Consensus Estimate. Higher revenues and assets under management (AUM) growth were partially offset by rise in expenses.
HD STI.WS.B STI.WS.A STI BK ETFC STI-A STI.PRE KEY

2
Can Loan Growth, Higher Rates Aid KeyCorp (KEY) Q2 Earnings?

2018-07-17 zacks
KeyCorp (KEY - Free Report) is slated to announce second-quarter 2018 results on Jul 19, before the opening bell. The company is expected to show some improvement in net interest income (NII), driven by higher interest rates, while the flattening of the yield curve is likely to hamper growth to some extent. While the overall loan growth in the second quarter was not impressive, commercial and industrial loans witnessed modest growth.
STI.WS.B STI.WS.A STI ETFC STI-A STI.PRE KEY

2
Is an Earnings Beat in Store for Blackstone (BX) in Q2?

2018-07-17 zacks
The Blackstone Group L.P. (BX - Free Report) is scheduled to report second-quarter 2018 results on Jul 19, before the opening bell. Its revenues and earnings are projected to grow on a year-over-year basis. In the last reported quarter, the company’s economic net income surpassed the Zacks Consensus Estimate. Growth in assets under management (AUM) was partially offset by a decline in revenues and higher expenses.
STI.WS.B STI.WS.A STI ETFC STI-A VEEV STI.PRE KEY SGH

2
E*TRADE (ETFC) to Report Q2 Earnings: Is a Beat in Store?

2018-07-17 zacks
E*TRADE Financial Corporation (ETFC - Free Report) is scheduled to report second-quarter 2018 results on Jul 19. The company is expected to witness year-over-year growth in revenues and earnings.
STI.WS.B STI.WS.A STI ETFC STI-A VEEV STI.PRE KEY SGH

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to KEY / KeyCorp on message board site Silicon Investor.

Keysight Technologies Hockey :: Stanley Cup Playoffs
Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) HAWKEYE Gold Grants 985,000 Incentive Stock Options
HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE GOLD PURCHASE TOP PROPERTY - YUKON
HAWKEYE GOLD. TSX SYMBOL - HGO News Links and Chart Links KEY POSTS
Buckeye Cellulose - BKI Low PE- High Growth The Donkeyu0027s Inn
CUSIP: 493267108